This is a service of EIN News a digital news provider
Get a Free Listing!
All Categories

2nd Annual Orphan Drug Congress 2012

Date: 07-Jun-12 to 08-Jun-12
Location: Barcelona / Barcelona / Spain
Category: Healthcare & Pharmaceuticals Science

When orphan drugs are still at the early stages of development,
the latest and most accurate information is required for the drug to advance efficiently.
Fleming Europe organizes the 2nd Annual Orphan Drug Congress 2012,
where worldwide pharmaceutical experts will share their experiences and insight.

Visitors

From pharmaceutical companies:
Presidents, VPs, Directors and Heads/Managers of
(within sectors – Oncology, CV, Respiratory, AutoImmune etc):
(Orphan) Drug Discovery/Development • Therapeutic Development • Marketing & Medical Affairs • Business Unit • Regulatory Affairs • External Affairs • Market Access

From biotechnology companies:
CEO • CMO • CSO • Corporate Development

Together with:
Regulatory Bodies • Academics • Research centres

Exhibitors

Segolene Ayme

INSERM
EU Commission
Director of Research

Martine Zimmerman

Alexion Pharmaceuticals
Switzerland
Executive Director Regulatory Affairs

Lise Aagaard

University of Copenhagen
Denmark
Associate Professor

Thomas Bertschik

Bayer
Germany
Strategic Marketing General Medicine

Samantha Parker

Orphan Europe
France
Orphan Europe Academy Manager

Andrea Rappagliosi

GSK Biologicals
Belgium
VP EU Government Affairs & Head of Brussels Office

Jakub Adamski

Ministry of Health
Poland
EU Policy Chief Expert

Pisana Ferrari

PHA Europe
Spain
Vice President

Juan Fuertes

PHA Europe
Spain
Coordinator General

Jens Oltrogge

Swedish Orphan Biovitrum
Germany

Alexion Pharmaceuticals

Switzerland

Go to event website